These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29518466)

  • 1. PEG-PGA enveloped octaarginine-peptide nanocomplexes: An oral peptide delivery strategy.
    Niu Z; Samaridou E; Jaumain E; Coëne J; Ullio G; Shrestha N; Garcia J; Durán-Lobato M; Tovar S; Santander-Ortega MJ; Lozano MV; Arroyo-Jimenez MM; Ramos-Membrive R; Peñuelas I; Mabondzo A; Préat V; Teixidó M; Giralt E; Alonso MJ
    J Control Release; 2018 Apr; 276():125-139. PubMed ID: 29518466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuning the PEG surface density of the PEG-PGA enveloped Octaarginine-peptide Nanocomplexes.
    Samaridou E; Kalamidas N; Santalices I; Crecente-Campo J; Alonso MJ
    Drug Deliv Transl Res; 2020 Feb; 10(1):241-258. PubMed ID: 31646443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nose-to-brain delivery of enveloped RNA - cell permeating peptide nanocomplexes for the treatment of neurodegenerative diseases.
    Samaridou E; Walgrave H; Salta E; Álvarez DM; Castro-López V; Loza M; Alonso MJ
    Biomaterials; 2020 Feb; 230():119657. PubMed ID: 31837821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrophilic and Electroneutral Nanoparticles to Overcome Mucus Trapping and Enhance Oral Delivery of Insulin.
    Tan X; Yin N; Liu Z; Sun R; Gou J; Yin T; Zhang Y; He H; Tang X
    Mol Pharm; 2020 Sep; 17(9):3177-3191. PubMed ID: 32697099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligoarginine-modified biodegradable nanoparticles improve the intestinal absorption of insulin.
    Liu X; Liu C; Zhang W; Xie C; Wei G; Lu W
    Int J Pharm; 2013 May; 448(1):159-67. PubMed ID: 23538098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomimetic Viruslike and Charge Reversible Nanoparticles to Sequentially Overcome Mucus and Epithelial Barriers for Oral Insulin Delivery.
    Wu J; Zheng Y; Liu M; Shan W; Zhang Z; Huang Y
    ACS Appl Mater Interfaces; 2018 Mar; 10(12):9916-9928. PubMed ID: 29504398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming multiple gastrointestinal barriers by bilayer modified hollow mesoporous silica nanocarriers.
    Wang Y; Zhao Y; Cui Y; Zhao Q; Zhang Q; Musetti S; Kinghorn KA; Wang S
    Acta Biomater; 2018 Jan; 65():405-416. PubMed ID: 29037897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin.
    Shan W; Zhu X; Liu M; Li L; Zhong J; Sun W; Zhang Z; Huang Y
    ACS Nano; 2015 Mar; 9(3):2345-56. PubMed ID: 25658958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination Strategy with Complexation Hydrogels and Cell-Penetrating Peptides for Oral Delivery of Insulin.
    Fukuoka Y; Khafagy ES; Goto T; Kamei N; Takayama K; Peppas NA; Takeda-Morishita M
    Biol Pharm Bull; 2018; 41(5):811-814. PubMed ID: 29709919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional nanoparticles exploit the bile acid pathway to overcome multiple barriers of the intestinal epithelium for oral insulin delivery.
    Fan W; Xia D; Zhu Q; Li X; He S; Zhu C; Guo S; Hovgaard L; Yang M; Gan Y
    Biomaterials; 2018 Jan; 151():13-23. PubMed ID: 29055774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced oral bioavailability of insulin using PLGA nanoparticles co-modified with cell-penetrating peptides and Engrailed secretion peptide (Sec).
    Zhu S; Chen S; Gao Y; Guo F; Li F; Xie B; Zhou J; Zhong H
    Drug Deliv; 2016 Jul; 23(6):1980-91. PubMed ID: 26181841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus-Mimicking Mesoporous Silica Nanoparticles with an Electrically Neutral and Hydrophilic Surface to Improve the Oral Absorption of Insulin by Breaking Through Dual Barriers of the Mucus Layer and the Intestinal Epithelium.
    Zhang Y; Xiong M; Ni X; Wang J; Rong H; Su Y; Yu S; Mohammad IS; Leung SSY; Hu H
    ACS Appl Mater Interfaces; 2021 Apr; 13(15):18077-18088. PubMed ID: 33830730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel nanoemulsion-based method to produce ultrasmall, water-dispersible nanoparticles from chitosan, surface modified with cell-penetrating peptide for oral delivery of proteins and peptides.
    Barbari GR; Dorkoosh FA; Amini M; Sharifzadeh M; Atyabi F; Balalaie S; Rafiee Tehrani N; Rafiee Tehrani M
    Int J Nanomedicine; 2017; 12():3471-3483. PubMed ID: 28496323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced oral absorption and anticancer efficacy of cabazitaxel by overcoming intestinal mucus and epithelium barriers using surface polyethylene oxide (PEO) decorated positively charged polymer-lipid hybrid nanoparticles.
    Ren T; Wang Q; Xu Y; Cong L; Gou J; Tao X; Zhang Y; He H; Yin T; Zhang H; Zhang Y; Tang X
    J Control Release; 2018 Jan; 269():423-438. PubMed ID: 29133120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational design of polyarginine nanocapsules intended to help peptides overcoming intestinal barriers.
    Niu Z; Tedesco E; Benetti F; Mabondzo A; Montagner IM; Marigo I; Gonzalez-Touceda D; Tovar S; Diéguez C; Santander-Ortega MJ; Alonso MJ
    J Control Release; 2017 Oct; 263():4-17. PubMed ID: 28235590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and evaluation of viscosity-enhanced nanocarrier (VEN) for oral insulin delivery.
    Boushra M; Tous S; Fetih G; Korzekwa K; Lebo DB; Xue HY; Wong HL
    Int J Pharm; 2016 Sep; 511(1):462-472. PubMed ID: 27418563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates.
    Sheng J; He H; Han L; Qin J; Chen S; Ru G; Li R; Yang P; Wang J; Yang VC
    J Control Release; 2016 Jul; 233():181-90. PubMed ID: 27178809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyglutamic Acid Functionalization of Chitosan Nanoparticles Enhances the Therapeutic Efficacy of Insulin Following Oral Administration.
    Urimi D; Agrawal AK; Kushwah V; Jain S
    AAPS PharmSciTech; 2019 Feb; 20(3):131. PubMed ID: 30815757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penetratin derivative-based nanocomplexes for enhanced intestinal insulin delivery.
    Zhu X; Shan W; Zhang P; Jin Y; Guan S; Fan T; Yang Y; Zhou Z; Huang Y
    Mol Pharm; 2014 Jan; 11(1):317-28. PubMed ID: 24255985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic study of the uptake/permeation of cell-penetrating peptides across a caco-2 monolayer and their stimulatory effect on epithelial insulin transport.
    Kamei N; Onuki Y; Takayama K; Takeda-Morishita M
    J Pharm Sci; 2013 Nov; 102(11):3998-4008. PubMed ID: 23963728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.